Vancomycin resistant Staphylococcus aureus infections: A review of case updating and clinical features

The infection caused by methicillin-resistant Staphylococcus aureus (MRSA) is a global threat to public health. Vancomycin remains one of the first-line drugs for the treatment of MRSA infections. However, S. aureus isolates with complete resistance to vancomycin have emerged in recent years. Vancom...

Descripción completa

Detalles Bibliográficos
Autores principales: Cong, Yanguang, Yang, Sijin, Rao, Xiancai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015472/
https://www.ncbi.nlm.nih.gov/pubmed/32071785
http://dx.doi.org/10.1016/j.jare.2019.10.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015472/
https://www.ncbi.nlm.nih.gov/pubmed/32071785
http://dx.doi.org/10.1016/j.jare.2019.10.005

Ejemplares similares